638
Views
48
CrossRef citations to date
0
Altmetric
Original Research

Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications

, , , , , , & show all
Pages 1761-1779 | Published online: 17 Apr 2012

References

  • SiegelRWardEBrawleyOJemalACancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deathsCA Cancer J Clin201161421223621685461
  • CareyLWinerEVialeGCameronDGianniLTriple-negative breast cancer: disease entity or title of convenience?Nat Rev Clin Oncol201071268369220877296
  • CareyLATriple-negative (basal-like) breast cancer: a new entityBreast Cancer Res20079Suppl 1S13
  • McGurkRFallowfieldLWintersZInformation provision for patients by breast cancer teams about the side-effects of hormone treatmentsEur J Cancer200642121760176716790339
  • SjovallKStrombeckGLofgrenABendahlPOGunnarsBAdjuvant radiotherapy of women with breast cancer – information, support and side-effectsEur J Oncol Nurs201014214715319896896
  • MooreSManaging treatment side effects in advanced breast cancerSemin Oncol Nurs2007234 Suppl 2S233018054679
  • Metzger FilhoOSainiKSAzimHAJrAwadaAPrevention and management of major side effects of targeted agents in breast cancerCrit Rev Oncol Hematol3152011 [Epub ahead of print.]
  • AnandPSundaramCJhuraniSKunnumakkaraABAggarwalBBCurcumin and cancer: an “old-age” disease with an “age-old” solutionCancer Lett2008267113316418462866
  • AggarwalBBBanerjeeSBharadwajUSungBShishodiaSSethiGCurcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell linesBiochem Pharmacol20077371024103217240359
  • HutzenBFriedmanLSoboMCurcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomasInt J Oncol200935486787219724924
  • RoweDLOzbayTO’ReganRMNahtaRModulation of the BRCA1 protein and induction of apoptosis in triple negative breast cancer cell lines by the polyphenolic compound curcuminBreast Cancer (Auckl)20093617519809577
  • AggarwalBBShishodiaSTakadaYCurcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude miceClin Cancer Res200511207490749816243823
  • GoelAAggarwalBBCurcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organsNutr Cancer201062791993020924967
  • YallapuMMMaherDMSundramVBellMCJaggiMChauhanSCCurcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJ Ovarian Res201031120429876
  • RavindranJPrasadSAggarwalBBCurcumin and cancer cells: how many ways can curry kill tumor cells selectively?AAPS J200911349551019590964
  • YallapuMMJaggiMChauhanSCCurcumin nanoformulations: a future nanomedicine for cancerDrug Discov Today2012171–2718021959306
  • BansalSSGoelMAqilFVadhanamMVGuptaRCAdvanced drug delivery systems of curcumin for cancer chemopreventionCancer Prev Res (Phila)2011481158117121546540
  • YallapuMMDobberpuhlMRMaherDMJaggiMChauhanSCDesign of curcumin loaded cellulose nanoparticles for prostate cancerCurr Drug Metab201213112012821892919
  • YallapuMMGuptaBKJaggiMChauhanSCFabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cellsJ Colloid Interface Sci20103511192920627257
  • YallapuMMJaggiMChauhanSCPoly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cellsMacromol Biosci201010101141115120572274
  • YallapuMMJaggiMChauhanSCBeta-cyclodextrin-curcumin selfassembly enhances curcumin delivery in prostate cancer cellsColloids Surf B Biointerfaces201079111312520456930
  • YallapuMMOthmanSFCurtisETGuptaBKJaggiMChauhanSCMulti-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapyBiomaterials20113271890190521167595
  • AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
  • LaurentSBridotJLElstLVMullerRNMagnetic iron oxide nanoparticles for biomedical applicationsFuture Med Chem20102342744921426176
  • ShubayevVIPisanicTRIIJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
  • YooDLeeJHShinTHCheonJTheranostic magnetic nanoparticlesAcc Chem Res2011441086387421823593
  • ColeAJYangVCDavidAECancer theranostics: the rise of targeted magnetic nanoparticlesTrends Biotechnol201129732333221489647
  • HoDSunXSunSMonodisperse magnetic nanoparticles for theranostic applicationsAcc Chem Res2011441087588221661754
  • JanibSMMosesASMacKayJAImaging and drug delivery using theranostic nanoparticlesAdv Drug Deliv Rev201062111052106320709124
  • TassaCShawSYWeisslederRDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapyAcc Chem Res2011441084285221661727
  • JainTKMoralesMASahooSKLeslie-PeleckyDLLabhasetwarVIron oxide nanoparticles for sustained delivery of anticancer agentsMol Pharm20052319420515934780
  • JainTKRicheyJStrandMLeslie-PeleckyDLFlaskCALabhasetwarVMagnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imagingBiomaterials200829294012402118649936
  • BhattaraiSRKcRBKimSYN-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imagingJ Nanobiotechnology20086118173857
  • SongMMoonWKKimYLimDSongICYoonBWLabeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide(CLIO)-NH2 and tat-CLIOKorean J Radiol20078536537117923778
  • YallapuMMEbelingMCChauhanNJaggiMChauhanSCInteraction of curcumin nanoformulations with human plasma proteins and erythrocytesInt J Nanomedicine201162779279022128249
  • GillisPKoenigSHTransverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetiteMagn Reson Med1987543233452824967
  • GuptaAKNaregalkarRRVaidyaVDGuptaMRecent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applicationsNanomedicine (Lond)200721233917716188
  • NamdeoMSaxenaSTankhiwaleRBajpaiMMohanYMBajpaiSKMagnetic nanoparticles for drug delivery applicationsJ Nanosci Nanotechnol2008873247327119051873
  • BanerjeeSSChenDHCyclodextrin conjugated magnetic colloidal nanoparticles as a nanocarrier for targeted anticancer drug deliveryNanotechnology2008192626560221828683
  • JainTKFoySPErokwuBDimitrijevicSFlaskCALabhasetwarVMagnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing miceBiomaterials200930356748675619765817
  • YallapuMMFoySPJainTKLabhasetwarVPEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applicationsPharm Res201027112283229520845067
  • LyJDGrubbDRLawenAThe mitochondrial membrane potential (deltapsi(m)) in apoptosis; an updateApoptosis20038211512812766472
  • ManjuSSreenivasanKConjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stabilityJ Colloid Interface Sci2011359131832521492865
  • ManjuSSreenivasanKSynthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugateJ Pharm Sci2011100250451120848656
  • MarcolinoVAZaninGMDurrantLRde BenassiMTMatioliGInteraction of curcumin and bixin with β-cyclodextrin: complexation methods, stability, and applications in foodJ Agric Food Chem20115973348335721381747
  • HeggeABSchullerRBKristensenSTonnesenHHIn vitro release of curcumin from vehicles containing alginate and cyclodextrin. Studies of curcumin and curcuminoides. XXXIIIPharmazie200863858559218771007
  • ShahaniKPanyamJHighly loaded, sustained-release microparticles of curcumin for chemopreventionJ Pharm Sci201110072599260921547911
  • UtrejaPJainSTiwaryAKNovel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospectsCurr Drug Deliv20107215216120158482
  • ChenWXuNXuLMultifunctional magnetoplasmonic nanoparticle assemblies for cancer therapy and diagnostics (theranostics)Macromol Rapid Commun201031222823621590896
  • BihariPVippolaMSchultesSOptimized dispersion of nanoparticles for biological in vitro and in vivo studiesPart Fibre Toxicol200851418990217
  • MahmoudiMLaurentSShokrgozarMAHosseinkhaniMToxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticlesACS Nano2011597263727621838310
  • MahmoudiMSimchiAMilaniASStroevePCell toxicity of superparamagnetic iron oxide nanoparticlesJ Colloid Interface Sci2009336251051819476952
  • FangJNakamuraHIyerAKTumor-targeted induction of oxystress for cancer therapyJ Drug Target2007157–847548617671894
  • PelicanoHCarneyDHuangPROS stress in cancer cells and therapeutic implicationsDrug Resist Updat2004729711015158766
  • JavvadiPSeganATTuttleSWKoumenisCThe chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathwayMol Pharmacol20087351491150118252805
  • MulikRSMonkkonenJJuvonenROMahadikKRParadkarARTransferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosisInt J Pharm20103981–219020320655375
  • AcharyaSSahooSKSustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapyBiomaterials201132245643566221600647
  • MisraRSahooSKCoformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cellsMol Pharm20118385286621480667
  • RautSLKirthivasanBBommanaMMSquillanteESadoqiMThe formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dyeNanotechnology2010213939510220820096
  • ChertokBDavidAEYangVCBrain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topographyJ Control Release2011155339339921763736
  • ChildHWDel PinoPADe La FuenteJMWorking together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3DACS Nano20115107910791921894941
  • ChenYCChangWHWangSJHsiehWYFluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imagingJ Biomater Sci Polym Ed2011 [Epub ahead of print.]
  • ShanXHHuHXiongFTargeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOsEur J Radiol2012811959921440393